Definitive Contract 75N93024C00052
Award Date
8/1/24
Potential Completion Date
7/31/26
Potential Value
$3M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Clear Labs Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Carlos, CA 94070, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, is for COVID-19 genomic sequencing services and related products. The $403,128.72 firm-fixed-price delivery order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 and has an ultimate completion date of September 30, 2025. Additionally, Clear Labs holds a $16 million single-award indefinite delivery contract (IDV) with the VA Veterans...
This is a federal contract award to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, by the U.S. Department of Veterans Affairs (VA). The $447,016.72 firm-fixed-price contract is for COVID-19 genomic sequencing services and related products, including reagents, consumables, automation tools, and software licenses. The contract has an ultimate completion date of September 30, 2024. Clear Labs has also been awarded a $16 million single-award indefinite delivery contract...
This $4,500 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company specializing in COVID-19 genomic sequencing services and related products. The contract is for the LYVE system relocation, with a completion date of May 27, 2024. Clear Labs has also received several other federal contracts and sub-awards from agencies like the Department of Veterans Affairs, National...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $59,850 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute. The contract is for the delivery of 150 clinical whole genome sequencing services, with a completion date of September 30, 2024. Broad Clinical Laboratories is a specialized healthcare services provider that offers genetic testing and clinical genome sequencing to federal agencies, particularly the Department...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Clear Labs Inc. to provide a CLEAR DX Instrument for COVID-19 testing and sequencing. The $232,327.60 contract was awarded on March 16, 2021 and has a completion date of April 14, 2022. This contract is not designated as a set-aside. Clear Labs Inc. is a for-profit manufacturer that has previously provided COVID-19 genomic sequencing services, reagents, and instrumentation...
This is a firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, for the maintenance of the CLEAR DX Instrument System. The contract has a ceiling value of $109,947.20 and a period of performance through May 31, 2026. Clear Labs previously received a $16 million indefinite delivery contract (IDC) from the VA in October 2022 to provide COVID-19 genomic sequencing services and associated...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions. The $78,446.81 firm fixed price delivery order is for COVID-19 research using Illumina brand name consumable kits. The contract has an ultimate completion date of June 15, 2023 and does not utilize any set-aside provisions. Illumina has previously received prime federal contract awards...
This federal contract award for $5,845.60 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the procurement of sequencing and cluster kits, with a period of performance ending on March 25, 2015. The contract was awarded on a firm fixed-price basis with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and...
This federal contract award, valued at $20,147.78, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The award was made to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the procurement of Illumina sequencing reagents. The contract has a firm fixed price and does not utilize any set-aside designations. Illumina holds two notable federal...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The award, valued at $71,253.00, was made to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the procurement of Illumina Sequencing Kits, which will be used to support the agency's scientific research and diagnostic initiatives. The contract does...